Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 6.70
0.00 (0.00%)
Jul 24, 2026, 3:08 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 15.73 million as of July 24, 2026. Its market cap has decreased by -87.41% in one year.
Market Cap
15.73M
Enterprise Value
366.15K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.70
ChartMarket Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 15.73M, a decrease of -92.04%. That is a compound annual growth rate of -39.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 15.73M | -83.05% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 75.42M |
| Ascelia Pharma AB | 68.10M |
| Pila Pharma AB | 58.02M |
| 2cureX AB | 57.94M |
| Modus Therapeutics Holding AB | 43.42M |
| Fluicell AB | 41.49M |
| Magle Chemoswed Holding AB | 35.71M |
| ExpreS2ion Biotech Holding AB | 33.01M |